Cumberland Pharmaceuticals Inc
Filings
Newest firstThe annual , the quarterly and the filed between them when something material happens.
- Sep 118-K/AShareholder vote (amended)5.07
- Aug 288-KRegulation FD disclosure7.01
- Aug 710-QQuarterly report
- Aug 48-KResults of operations2.029.01
- Jul 138-KOther events8.01
- Jul 18-KMaterial agreement and acquisition or sale of assets completed1.011.022.015.028.019.01
- Jun 258-KShareholder vote5.07
- May 810-QQuarterly report
- May 58-KResults of operations2.029.01
- Apr 248-KShareholder vote5.07
- Apr 238-KMaterial agreement and Regulation FD disclosure1.017.018.019.01
- Mar 710-KAnnual report
- Mar 38-KResults of operations2.029.01
- Feb 48-KOther events8.01
- Nov 22, 20258-KMaterial agreement and new debt or obligation1.012.03
- Nov 7, 202510-QQuarterly report
- Nov 4, 20258-KResults of operations2.029.01
- Oct 21, 20258-KOther events8.01
- Aug 8, 202510-QQuarterly report
- Aug 5, 20258-KResults of operations2.029.01
- May 9, 202510-QQuarterly report
- May 6, 20258-KResults of operations2.029.01
- Apr 28, 20258-KShareholder vote5.07
- Mar 19, 20258-KOther events8.01
- Mar 7, 202510-KAnnual report
- Mar 4, 20258-KResults of operations2.029.01
- Feb 19, 20258-KOther events8.01
- Feb 14, 2025424B5Prospectus for an offering
- Feb 14, 20258-KOther events8.019.01
- Feb 4, 20258-KOther events8.01
- Dec 9, 20248-KOther events8.01